MC

Mey Capital Matrix

Europe, Bayern, Germany, München

Description

The MEY Capital Matrix GmbH is a company which helps to reduce healthcare cost and provides personalized medicines.

Investor Profile

Mey Capital Matrix has made 7 investments, with 0 in the past 12 months and 57% as lead.

Stage Focus

  • Series A (29%)
  • Seed (29%)
  • Series C (14%)
  • Series B (14%)
  • Series D (14%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Therapeutics
  • Food And Beverage
  • Organic Food
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mey Capital Matrix frequently co-invest with?

GreyBird Ventures
North America, Massachusetts, United States, Concord
Co-Investments: 1
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 2
BayBG Venture Capital
Europe, Bayern, Germany, München
Co-Investments: 2
WB
Europe, Bayern, Germany, München
Co-Investments: 2
b2venture
Europe, Berlin, Germany, Berlin
Co-Investments: 2
OCCIDENT
Europe, Bayern, Germany, Munich
Co-Investments: 2
SHS Capital
Europe, Baden-Wurttemberg, Germany, Tübingen
Co-Investments: 2
Bosch Ventures
Europe, Baden-Wurttemberg, Germany, Stuttgart
Co-Investments: 2
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
UVC Partners
Europe, Bayern, Germany, Garching
Co-Investments: 2

Which angels does Mey Capital Matrix often collaborate with?

CW
Europe, Catalonia, Spain, Torredembarra
Shared Deals: 1
TO
Europe, Berlin, Germany, Berlin
Shared Deals: 1
WH
Europe, Berlin, Germany, Berlin
Shared Deals: 1

What are some of recent deals done by Mey Capital Matrix?

Pumpkin Organics

Munich, Bayern, Germany

Pumpkin Organics is an innovative baby food concept.

Food and BeverageHealth CareOrganic Food
SeedMay 17, 2023
Amount Raised: $4,300,000
iThera Medical

München, Bayern, Germany

iThera Medical focuses on the development of proprietary MSOT technology for use in preclinical and clinical applications.

BiotechnologyHealth CareMedical
Series DDec 21, 2022
Amount Raised: $13,790,470
GNA Biosolutions

Munich, Bayern, Germany

GNA Biosolutions is a private molecular diagnostics company.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series CAug 6, 2019
Amount Raised: $13,500,000
GNA Biosolutions

Munich, Bayern, Germany

GNA Biosolutions is a private molecular diagnostics company.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BMar 7, 2015
Amount Raised: $6,506,110
ConoGenetix biosciences

Martinsried, Bayern, Germany

ConoGenetix biosciences is a biotechnology company that focuses on the development of peptide-based drugs.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AApr 23, 2012
Amount Raised: $1,971,373
iThera Medical

München, Bayern, Germany

iThera Medical focuses on the development of proprietary MSOT technology for use in preclinical and clinical applications.

BiotechnologyHealth CareMedical
Series ANov 23, 2011
Soluventis

Bochum, Nordrhein-Westfalen, Germany

This company is developing a new class of oligonucleotide therapeutics based on its proprietary platform technology.

BiotechnologyTherapeutics
SeedFeb 1, 2011